|
| Status |
Public on Jan 28, 2020 |
| Title |
H3122, in vitro resistance to ALK inhibitors |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures
|
| |
|
| Overall design |
6 samples comparing drug naïve cells to cells resistant to various ALK inhibitors, no replicates
|
| |
|
| Contributor(s) |
Vander Velde RJ, Marusyk A |
| Citation(s) |
32409712 |
| |
| Submission date |
Jan 27, 2020 |
| Last update date |
May 19, 2020 |
| Contact name |
Robert Vander Velde |
| E-mail(s) |
r-velde@hotmail.com
|
| Phone |
8138422463
|
| Organization name |
H. Lee Moffitt Cancer Center
|
| Street address |
12902 USF Magnolia Drive
|
| City |
Tampa |
| State/province |
FL |
| ZIP/Postal code |
33612 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
| Samples (8)
|
|
| Relations |
| BioProject |
PRJNA603304 |
| SRA |
SRP245363 |
Less...
More...